Researchers warn that the public, policy makers and even clinicians are not aware of the growing problem of liver cancer.

Fatty liver disease is one of the fastest-growing health concerns worldwide, impacting roughly 32% of people worldwide, according to a 2022 systematic review. It is closely tied to rising rates of ...

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...

Sixty percent of liver cancers are preventable by controlling risk factors including hepatitis B and C, alcohol consumption, ...

Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) and aging are locked in a vicious circle: ...

MASLD is highly prevalent among individuals with chronic hepatitis B and increases the risk for liver fibrosis.

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), affecting approximately 30% of the global population, represents a spectrum of liver disorders ranging from simple steatosis to ...

Poor dietary habits and obesity are key contributors to non-alcoholic fatty liver disease (NAFLD).leading to inflammation and ...

A recent study reveals that 60% of liver cancer cases are preventable by addressing key risk factors such as viral hepatitis, ...

The stigma of liver disease is all too common, whether it’s MASLD or other ones, like cirrhosis. One study published in 2022 found that 69% of patients with MASLD said they were stigmatized in ...

MASLD is one of the most common forms of chronic liver disease, and it’s related to how your liver stores fat. The more fat there is in your liver, the more it becomes inflamed.